3M has raised its 2026 profit outlook after a forecast-beating second quarter, sending the shares to fresh highs. With organic growth accelerating and adjusted margins near 25%, the industrial icon's multi-year turnaround suddenly looks convincing — but a wall of legacy litigation still hangs over the story.

On 21 July 2026, 3M reported second-quarter results that comfortably beat Wall Street expectations and, crucially, lifted its full-year adjusted Earnings guidance again. Adjusted Earnings Per Share of $2.40 topped the $2.25 analysts had pencilled in, Revenue edged past forecasts at $6.5bn, and the shares jumped more than 7% on the day to around $171. For a company that spent years mired in litigation, slowing growth and management churn, it was a striking statement of momentum.

3M makes tens of thousands of products — from Post-it notes and Scotch tape to industrial abrasives, electronic materials and safety equipment — sold into virtually every corner of the global economy. Investors care because the Minnesota giant has been trying to prove that chief executive William 'Bill' Brown's disciplined-execution playbook can reignite growth. The headline asks whether the turnaround is entering a new gear; the numbers offer a genuinely encouraging, if incomplete, answer.

What the Company Does

3M is a diversified American industrial conglomerate built on materials science. It reports across three segments. Safety and Industrial — its largest — sells abrasives, adhesives, tapes, electrical products and personal-safety gear, and generated $3.09bn of revenue in the quarter with organic growth above 8%. Transportation and Electronics supplies films, semiconductor and data-centre materials and automotive components, contributing $2.07bn, up 6.2%. A Consumer segment covers familiar retail brands such as Post-it, Scotch and Command.

The appeal of 3M has always been breadth: a vast catalogue of often-patented products embedded in customers' processes and sold globally through deep distribution. That Diversification cushions any single end-market's weakness — in the latest quarter, strength in electrical markets, data centres and semiconductors offset soft automotive demand. The flip side, which dogged 3M for years, is that scale and complexity can dull growth and invite the kind of legacy liabilities that came to define its recent past.

Why the Stock Is in Focus

The catalyst is simple: growth is accelerating and management keeps raising the bar. Adjusted Organic Sales rose 5.4% in the quarter — mid-single-digit growth that would have seemed fanciful a couple of years ago — while adjusted operating margins reached about 25%. On the back of a strong first half, 3M raised its full-year adjusted EPS guidance to $8.80–$8.95, up from $8.50–$8.70 previously and ahead of the $8.74 consensus. It also nudged its organic growth target above 3.5%, from around 3%, and guided to 70–80 basis points of operating-margin expansion. Bill Brown framed it as 'disciplined execution' and 'continued momentum'. The market agreed, marking the stock up sharply.

Latest Financial Picture

Second-quarter revenue was $6.5bn, up 2.4% as reported. Adjusted EPS of $2.40 rose 11% year on year, while GAAP EPS jumped 33% to $1.78. The gap between the two measures matters: adjusted operating Margin improved to 24.9% (from 24.5%), but GAAP Operating Margin fell to 15.1% from 18.0%, a reminder that special items — including litigation-related costs — still distort the statutory picture.

3M generated $1.0bn of Operating Cash Flow and $1.3bn of adjusted free cash flow in the quarter, and returned $1.4bn to shareholders via dividends and buybacks. The annual Dividend stands at $3.12 per share, a Yield of roughly 1.7%. For the full year, management guided to adjusted operating cash flow of $5.8–$6.0bn.

The Bull Case

The bull case is that a genuine operational turnaround is taking hold. Organic growth has moved from stagnant to mid-single-digit, margins are expanding, and management has now raised guidance rather than merely defended it — a meaningful shift in credibility. The growth is coming from structurally attractive places: data centres and semiconductors, riding the same AI-driven capital-spending wave lifting much of the technology Supply chain. Free cash flow is robust, funding a dividend and Buybacks worth $1.4bn in a single quarter. If Brown can sustain mid-single-digit growth with roughly 25% adjusted margins, 3M's earnings power looks materially higher than the depressed levels of a couple of years ago.

The Bear Case

The bears start with the litigation overhang. 3M agreed in 2023 to pay up to $10.3bn — potentially as much as $12.5bn — to resolve US public-water-system claims over PFAS 'forever chemicals', and around $6bn ($5bn cash plus $1bn in stock) to settle Combat Arms earplug litigation, with payments stretching for years. Those cash outflows, plus wider PFAS uncertainty, remain a drag on statutory earnings and a Tail risk to the balance sheet. Beyond litigation, much of the recent gain is self-help — cost discipline and margin recovery — which is harder to repeat indefinitely, while underlying Demand in areas such as autos remains soft. The valuation has also re-rated as the shares recovered, leaving less room for disappointment, and a modest ~1.7% yield offers thinner support than 3M's income reputation once implied.

What Could Move the Stock Next?

The next scheduled catalyst is third-quarter 2026 results, due in the autumn, where investors will look for confirmation that mid-single-digit organic growth and margin expansion are sustainable rather than a first-half quirk. Progress and cash timing on the PFAS and earplug settlements — and any fresh regulatory developments around 'forever chemicals' — could swing sentiment either way. Trade and Tariff policy affecting 3M's global Manufacturing footprint, the trajectory of data-centre and semiconductor demand, and the pace of any recovery in automotive and consumer markets are the main external variables. Capital returns — the size of future buybacks and dividend growth — will also matter to a Shareholder base that prizes income.

Outlook

Is the turnaround entering a new gear? On the evidence to 12 August 2026, the operational case has clearly strengthened: 3M beat expectations, accelerated organic growth to 5.4%, pushed adjusted margins to around 25% and raised full-year EPS guidance to $8.80–$8.95, with the shares responding in kind. That is the profile of a Business executing well, not merely stabilising. The important caveat is that the legacy litigation — multi-billion-dollar PFAS and earplug settlements — still weighs on statutory profits and long-term cash. None of this is a recommendation. But for the first time in a while, the bull narrative around 3M rests on improving fundamentals rather than hope, even if the courtroom shadow has not fully lifted.